
Matt Reaney, PhD, CPsychol, CSci, FRSPH, AFBPsS, MSc, PGDip
Chief Scientific Officer
Matt is Vitaccess’ Chief Scientific Officer, leading the scientific strategy underpinning our patient-centred research, measurement science and digital innovation activities. He is a Chartered and Practitioner Health Psychologist, a Chartered Scientist, a Fellow of both the Royal Societies of Medicine and Public Health, and an Associate Fellow of the British Psychological Society. He is also a Visiting Lecturer at Royal Holloway, University of London.
With more than 20 years’ experience spanning pharma, consultancy, academia and the NHS, Matt has held senior patient-centred research and scientific leadership roles at organisations including IQVIA, Sanofi, Eli Lilly, Oxford Outcomes and ERT. Prior to joining Vitaccess, he led the Patient-Centered Solutions (PCS) Scientific and Analytic teams and the PCS Institute at IQVIA. He also serves as co-chair of the Drug Information Association (DIA) Study Endpoints Group, sits on the Scientific Advisory Board at Breakthrough T1D, and contributes to the editorial boards of several journals.
Curious to see this work in action? Explore the Vitaccess publications – our sample library can be found on our publications page.